Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Buildings: 2021-2025

  • Mesa Laboratories' Buildings fell 0.85% to $23.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $23.3 million, marking a year-over-year decrease of 0.85%. This contributed to the annual value of $23.3 million for FY2025, which is 0.85% down from last year.
  • According to the latest figures from Q1 2025, Mesa Laboratories' Buildings is $23.3 million, which was down 0.85% from $23.5 million recorded in Q1 2024.
  • Mesa Laboratories' 5-year Buildings high stood at $23.5 million for Q1 2024, and its period low was $18.9 million during Q1 2021.
  • In the last 3 years, Mesa Laboratories' Buildings had a median value of $23.3 million in 2025 and averaged $22.9 million.
  • As far as peak fluctuations go, Mesa Laboratories' Buildings rose by 14.21% in 2022, and later declined by 0.85% in 2025.
  • Mesa Laboratories' Buildings (Quarterly) stood at $18.9 million in 2021, then climbed by 14.21% to $21.5 million in 2022, then rose by 2.17% to $22.0 million in 2023, then rose by 6.70% to $23.5 million in 2024, then fell by 0.85% to $23.3 million in 2025.
  • Its last three reported values are $23.3 million in Q1 2025, $23.5 million for Q1 2024, and $22.0 million during Q1 2023.